| Trial ID: | L0087 |
| Source ID: | NCT01210989
|
| Associated Drug: |
Hepaguard
|
| Title: |
Trial of Hepaguard?? in Adults With Nonalcoholic Steatohepatitis
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Fatty Liver Disease
|
| Interventions: |
Drug: Phyllanthus urinaria|Drug: Placebo
|
| Outcome Measures: |
Histologic NAFLD activity score|ALT normalization|Metabolic endpoints|Changes in magnetic resonance spectroscopy|Liver stiffness measurement|Biomarkers of NASH and liver fibrosis
|
| Sponsor/Collaborators: |
Chinese University of Hong Kong
|
| Gender: |
All
|
| Age: |
18 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Not applicable
|
| Enrollment: |
60
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
May 2010
|
| Completion Date: |
May 2012
|
| Results First Posted: |
--
|
| Last Update Posted: |
February 24, 2014
|
| Locations: |
Cheng Suen Man Shook Hepatitis Center, Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China
|
| URL: |
https://ClinicalTrials.gov/show/NCT01210989
|
